Physician profile
Patrick M Weix
NPI 1033103072
$95,634.94
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.82 · 2020: $499 · 2021: $18K · 2022: $21K · 2023: $19K · 2024: $23K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Travel and Lodging: $9,256 · Food and Beverage: $2,084 · Consulting Fee: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,500.00 |
| Travel and Lodging | $9,255.92 |
| Food and Beverage | $2,084.35 |
| Consulting Fee | $737.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $94,106.45 | 2020-2025 | Gelpoint V-Path |
| Medical Device Business Services, INC. | $325.00 | 2020 | |
| Davol INC. | $256.50 | 2022-2025 | Arista |
| Astellas Pharma US INC | $240.69 | 2022-2024 | Veozah |
| Baxter Healthcare | $147.91 | 2025 | Perclot |
| Becton, Dickinson and Company | $93.27 | 2022 | |
| Abbvie INC. | $71.45 | 2020-2022 | |
| Gynesonics, INC. | $55.31 | 2023-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $40.58 | 2020-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $36.09 | 2023 | |
| Meditrina | $36.04 | 2022-2023 | |
| Olympus America INC. | $35.82 | 2019 | |
| Exeltis, USA INC. | $35.38 | 2022-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $31.58 | 2023 | |
| Hologic Sales and Service, LLC | $25.78 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $18.34 | 2023 | Intrarosa |
| Ascend Therapeutics US, LLC | $18.05 | 2023 | |
| Agile Therapeutics, INC. | $16.99 | 2021 | |
| Sumitomo Pharma America, INC. | $14.89 | 2023 | Myfembree |
| Insulet Corporation | $14.81 | 2023 | Omnipod |
| Minerva Surgical, INC | $14.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Weix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.